Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience (P5-18.006)

Kelly Leyden; Gargi Datta; Jennifer Chester; Terrie Livingston

doi:10.1212/wnl.0000000000217302

June 9, 2026Neurology

Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience (P5-18.006)

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to evaluate the provider experience and perceived clinical utility of the MSDA blood test for multiple sclerosis.
Providers assessed the MSDA blood test during routine clinical practice.
Survey feedback was collected from providers regarding usability and utility.
Analyzed perceived impact on patient management and decision-making.
Providers reported improved confidence in managing MS patients using the MSDA test.
70% of providers found the MSDA test easy to interpret, with positive implications for patient care.
Feedback indicated a shift in clinical decision-making based on test results.

Implication

Evaluates the clinical utility of the MSDA blood test in routine practice, suggesting improved provider experience.

Abstract

Evaluate provider experience and perceived clinical utility of the multi-protein Multiple Sclerosis Disease Activity (MSDA) blood test in routine clinical practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Leyden et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf3b4faef96ed7f056346 https://doi.org/10.1212/wnl.0000000000217302

View Full Paper

Ask AI

Bookmark

Share

Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience (P5-18.006)

Key Points

Implication

Abstract

Discussion

Cite This Study

Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience (P5-18.006)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading